McGuireWoods has long been an avid supporter of the advancement of professional women. As part of our initiative seeking to expand the leadership of women in private equity, we are continuing our series of profiling women leaders in private equity. We are hopeful that this series will serve to inspire other women to pursue their careers in private equity in a way that best challenges and motivates them, which these impressive women have all done. We are pleased to feature Erin Lansky of Blue Sea Capital. Access her profile.

To recommend a woman for a future interview, email Amber Walsh at awalsh@mcguirewoods.com.

Vestar Capital Partners has completed a strategic growth investment in Nox Health, according to a news release

Nox, based in Alpharetta, Ga., is a global sleep health company. Founded in 2007, the company provides technology and program solutions to help diagnose and manage sleep problems.

Vestar Capital Partners, based in New York, is a private equity firm focused on middle market companies. Founded in 1988, the firm prefers to make more substantial investments from a dollars perspective in businesses from a few sectors, including healthcare.

Terms of the investment were not disclosed.

Viewside Capital Partners and Morningside Group have co-led a $15 million series A funding round in Resilience Lab, according to a news release.

Resilience Lab, based in New York, is a mental health technology company. Founded in 2019, the company’s platform is designed to help clients connect to therapists and participate in in-person, telehealth or hybrid sessions. 

Viewside, based in Dallas, is a healthcare private equity firm. The firm is focused on making $3 million to $15 million growth equity investments in small and middle market companies within the healthcare technology and service sectors.

Morningside, based in Boston and founded in 1986, makes private equity and venture capital investments in the science and technology sectors. 

Kain Capital has announced it has acquired Hospice Care of America (HCA).

HCA, founded in 2004 and based in Kansas City, operates a group of affiliated hospices in Kansas, Missouri, Oklahoma and Colorado.

Kain, based in New York and founded in 2014, is a private equity firm focused on investments in healthcare services and information technology companies.

The acquisition of HCA was announced in conjunction with Kain announcing the formation of PERA Holdings, a new holding company for hospice investments.

Terms of the acquisition were not disclosed.

Accelmed Partners has announced it has invested $35 million in SKNV.

SKNV, based in Pompano Beach, Fla., develops medications and skincare solutions for dermatology practices. Founded in 2016 and formerly Sincerus Pharmaceuticals and Prescriber’s Choice, SKNV states it produces medicines for the 12 most common dermatological diagnoses.

Accelmed, based in Aventura, Fla., is a private equity firm focused on acquiring and investing in U.S. commercial stage, lower middle market health technology companies. Founded in 2009, the firm targets equity investments of $10 million to $50 million per transaction in medical devices, diagnostics, digital health and technology-enabled healthcare services.

A press release on the investment noted that proceeds from the round will be used to help SKNV advance its new manufacturing facility, scale its digital health platform, increase its sales team footprint across the United States and expand its management team.

The Vistria Group and GHO Capital Partners will acquire a controlling interest in Alcami Corp. from Madison Dearborn Partners (MDP) and Ampersand Capital Partners, according to a news release.

Alcami, based in Wilmington, N.C., is a contract development, testing and manufacturing organization for pharma and biotech companies. Founded in 1979, the company provides solutions for analytical development, clinical to commercial sterile and oral solid manufacturing, packaging, microbiology, cGMP biostorage, environmental monitoring and pharmaceutical support services.

The Vistria Group, based in Chicago, focuses on making investments in middle market companies in healthcare and a few other industries. Founded in 2013, the firm pursues control and minority equity investments and prefers to make more substantial investments from a dollars perspective in companies with at least $100 million in revenue.

GHO Capital Partners, or Global Healthcare Opportunities, is a London-based specialist healthcare investor.

MDP, based Chicago, pursues management buyouts and structured minority investments. Founded in 1992, the firm focuses on value-oriented mature businesses and growth-oriented companies in several industries, including healthcare.

Ampersand, based in Wellesley, Mass., is a middle market private equity firm with a focus on growth equity investments in the healthcare sector. Founded in 1988, the firm typically pursues majority or minority positions in companies generating between $10 million and $100 million in revenue.

Terms of the transaction were not disclosed.

GTCR has announced it has acquired Biocoat Holdings.

Biocoat, based in Horsham, Pa., is a provider of medical coatings products and services for medical devices in the interventional sector. Founded in 1991, the company specializes in biocompatible hydrophilic coatings.

GTCR, based in Chicago, pursues a wide range of investments in several industries, including healthcare. Founded in 1980, the firm prefers to make more substantial investments from a dollars perspective.

Terms of the acquisition were not disclosed.

Avista Capital Partners has announced its acquisition of Taconic Biosciences from H.I.G. Capital. 

Taconic, based in Rensselaer, N.Y., is a provider of genetically engineered research models and related services. Founded in 1952, the company specializes in murine models for use in drug discovery research and non-clinical safety testing.

Avista, based in New York, makes control buyout investments in middle market healthcare companies. Founded in 2005, the firm focuses on the following healthcare subsectors: pharmaceuticals, medical devices, outsourced pharmaceutical services, distribution and consumer-driven healthcare.

H.I.G. Capital, based in Miami, pursues a wide range of investments in healthcare and many other industries. Founded in 1993, the firm has flexibility on investment size, including interest in pre-EBITDA businesses. Within healthcare, the firm targets companies in the provider services, hospital/major facilities and life sciences/pharmaceutical industries.

Terms of the transaction were not disclosed.

RC Capital (RCC) has announced it has closed a growth and recapitalization investment in Cognitive Research Corporation (CRC).

CRC, based in St. Petersburg, Fla., is contract research organization that specializes in central nervous system product development. Founded in 2006, the company sells to pharmaceutical, nutraceutical, biotechnology and medical device companies.

RCC, based in Cincinnati, Ohio, is healthcare-focused private equity firm. Founded in 1994, the firm focuses on investments into medical device, healthcare services and healthcare IT companies.

Terms of the investment were not disclosed.

McGuireWoods has long been an avid supporter of the advancement of professional women. As part of our initiative seeking to expand the leadership of women in private equity, we are continuing our series of profiling women leaders in private equity. We are hopeful that this series will serve to inspire other women to pursue their careers in private equity in a way that best challenges and motivates them, which these impressive women have all done. We are pleased to feature Pavithra Mahesh of Apax. Access her profile.

To recommend a woman for a future interview, email Amber Walsh at awalsh@mcguirewoods.com.